Experientia

, Volume 37, Issue 9, pp 913–917

The influence of synthetic DSIP (delta-sleep-inducing-peptide) on disturbed human sleep

  • D. Schneider-Helmert
  • G. A. Schoenenberger
Generalia

Summary

The effects of acute intravenous administration of synthetic DSIP, 25 nmoles/kg b. wt, on disturbed human sleep were tested in 6 middle-aged chronic insomniacs. The results were: longer sleep duration and a higher quality of sleep with fewer interruptions; slightly more REM-sleep, but no day-time sedation or other side effects though the sleep enhancing capacity was seen for up to 6 h of night sleep. Sleep-promoting effects occurred only in the second hour after injection, in the first hour a slight arousing effect was indicated. The study corroborates the findings of previous investigations in healthy subjects and shows that DSIP has a normalizing influence on human sleep regulation.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Blois R., Monnier M., Schoenenberger G.A., Tissot R., and Gaillard J.-M., 1980. Effect of DSIP on diurnal and nocturnal sleep in man. 5th Eur. Sleep Congr., Amsterdam. Abstracts, p. 16.Google Scholar
  2. Gnirss F., Schneider-Helmert, D., Schenker J., Tobler H.J., and Schoenenberger G.A., 1980. Pilot study on the sleep inducing capacity of DSIP in humans. Sleep Res.9, 51.Google Scholar
  3. Graf M., Monnier M., Schneider-Helmert D., and Schoenenberger G.A. 1980. DSIP: A circadian ‘pace-maker’? In: Progress in Neuro-Pharmacology, p. 251. Ed. Radouco-Thomas C., Garcia F. Pergamon Press, Oxford-New York-Toronto-Sydney-Paris-Frankfurt.Google Scholar
  4. Graf M., Christen H., Tobler H.J., Baumann, J.B., and Schoenenberger G.A., 1981. DSIP — A circadian ‘programming’ substance? Experientia37, 22.Google Scholar
  5. Graf M., Lorez H.P., Gillesen D., Tobler H.J., and Schoenenberger G.A., 1981. Distribution and specific binding of3H-DSIP. Experientia37, 23.Google Scholar
  6. Hoddes E., Zarcone V., Smythe H., Phillips R., and Dement W. C., 1973. Quantification of sleepiness: a new approach. Psychophysiology10, 431.PubMedGoogle Scholar
  7. Huang J.-T., and Lajtha A., 1978. The degradation of a nonapeptide, sleep-inducing-peptide, in rat brain: comparison with enkephalin breakdown. Res. Commun. chem. Path. Pharm.19, 191.PubMedGoogle Scholar
  8. Janke W., and Debus G., 1978. Die Eigenschaftswörterliste-EWL. Hogrefe, Göttingen-Toronto-Zürich.Google Scholar
  9. Kafi S., Monnier M., and Gaillard J.-M., 1979. The delta-sleep-inducing-peptide (DSIP) increases duration of sleep in rats. Neurosci. Lett.13, 169.CrossRefPubMedGoogle Scholar
  10. Kastin A.J., Nissen C., Schally A.V., and Coy D.H., 1978. Radioimmuno-assay of DSIP-like material in rat brain. Brain Res. Bull.3, 691.CrossRefPubMedGoogle Scholar
  11. Kastin A.J., Nissen C., Schally A.V., and Coy D.H., 1979. Additional evidence that small amounts of a peptide can cross the blood-brain barrier. Pharmac. Biochem. Behav.11, 717.CrossRefGoogle Scholar
  12. Kastin A.J., Olson G.A., Schally A.V., and Coy D.H., 1980. DSIP — more than a sleep peptide? TINS25, 163.Google Scholar
  13. Marks N., Stern F., Kastin A.J., and Coy D.H., 1977. Degradation of delta-sleep-inducing-peptide (DSIP) and its analogs by brain extracts. Brain Res. Bull.2, 491.CrossRefPubMedGoogle Scholar
  14. Monnier M., Dudler L., Gächter R., Maier P.F., Tobler H.J., and Schoenenberger G.A., 1977. The delta-sleep-inducing-peptide (DSIP). Comparative properties of the original and synthetic nonapeptide. Experientia33, 548.CrossRefPubMedGoogle Scholar
  15. Monnier M., Hatt A.M., Cueni L.B., and Schoenenberger G.A., 1972. Humoral transmission of sleep. VI. Purification and assessment of a hypnogenic fraction of ‘sleep dialysate’; factor delta. Pflügers Arch.331, 257.CrossRefGoogle Scholar
  16. Monnier M., and Hösli L. 1965. Humeral transmission of sleep and wakefulness. II. Hemodialysis of sleep inducing humor during stimulation of the thalamic hypnogenic area. Pflügers Arch.282, 60.CrossRefGoogle Scholar
  17. Nagasaki H., Kitahama K., Valatx J.-L., and Jouvet M., 1980. Sleep-promoting effect of the sleep-promoting substance (SPS) and delta-sleep-inducing-peptide (DSIP) in the mouse. Brain Res.192, 276.CrossRefPubMedGoogle Scholar
  18. Polc P., Schneeberger J., and Haefely W., 1978. Effect of the delta-sleep-inducing-peptide (DSIP) on the sleep-wakefulness cycle of cats. Neurosci. Lett.9, 33.CrossRefGoogle Scholar
  19. Rechtschaffen A., and Kales A., eds, 1968. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. National Institute of Health, Washington/USAGoogle Scholar
  20. Scherschlicht R., 1990. Zwölf Jahre Schlafforschung: Ein Erkenntnisstand-Vergleich. Roche Magazin9, 4.Google Scholar
  21. Scherschlicht R., Schneeberger J., Steiner M., and Haefely W., 1979. Delta-sleep-inducing-peptide antagonizes morphine insomnia in cats. Sleep Res.8, 84.Google Scholar
  22. Schneider-Helmert D., Gnirss F., Monnier M., Schenker J., and Schoenenberger G.A., 1981. Acute and delayed effects of DSIP (delta-sleep-inducing-peptide) on human sleep behavior. Clin Pharmac., in press.Google Scholar
  23. Schneider-Helmert D., 1981. Clinical and conceptual aspects of sleep and emotional stress, in: Sleep 1980, Proc. 5th Eur. Congr. Sleep Research. Karger, Basel, in press.Google Scholar
  24. Schoenenberger G.A., Maier P.F., Tobler H.J., and Monnier M., 1977. A naturally occurring delta-EEG enhancing nonapeptide in rabbits. X. Final isolation, characterization and activity test. Pflügers Arch.369, 99.CrossRefGoogle Scholar
  25. Schoenenberger G.A., Maier P.F., Tobler H.J., Wilson K., and Monnier M., 1978. The delta-EEG-(sleep)-inducing-peptide (DSIP). XI. Amino acid analysis, sequence, synthesis and activity of the nonapeptide. Pflügers Arch.376, 119.CrossRefGoogle Scholar
  26. Schoenenberger G.A., and Monnier M., 1977. Characterization of a delta-electroencephalogramm-(sleep)-inducing-peptide. Proc. natl Acad. Sci.74, 1282.PubMedGoogle Scholar
  27. Schoenenberger G.A., and Monnier M., 1979. Studies on the delta-(sleep)-inducing-peptide, in: IUPAC Medical Chemistry Proceedings, p. 101. VIth Int. Symp. Med. Chem., Brighton 1978. Cotwold Press, Oxford.Google Scholar
  28. Williams R.L., Karacan I., and Hursch C.J., 1974. EEG of human sleep: Clinical applications. John Wiley & Sons. New York-London-Sydney-Toronto.Google Scholar
  29. Yehuda S., Kastin A.J. and Coy D.H., 1980. Thermoregulatory and locomotor effects of DSIP: Paradoxical interactions with D-amphetamine. Pharmac. Biochem. Behav.13, 895.CrossRefGoogle Scholar

Copyright information

© Birkhüuser Verlag 1981

Authors and Affiliations

  • D. Schneider-Helmert
    • 1
    • 2
  • G. A. Schoenenberger
    • 1
    • 2
  1. 1.Psychiatric ClinicResearch Department/Sleep LaboratoriesKönigsfelden(Switzerland)
  2. 2.Research Division, Department of Surgery/Research Department KantonsspitalUniversity of BaselBasel(Switzerland)

Personalised recommendations